MBS Digest Vol. 2, Issue 10: Surgery in multimodal care, liver biopsy, and In Memoriam

Surgery within multimodal care, the yield and risks of liver biopsy, what newer obesity treatments still need to prove — and a tribute to Tomasz Rogula.

MBS Digest Vol. 2, Issue 8: AI transparency with patients and more

This week: Bariatric access and operative risk, comparative incretin evidence, and a widening GLP-1 pipeline

Las redes sociales sustituyen al médico en la educación sobre GLP-1 — y MÁS NOTICIAS

Las últimas noticias e investigación en medicina metabólica, AQUÍ

Social Media Replaces MDs for GLP1 Ed and MORE NEWS

Get the latest news and research on Metabolic Medicine HERE

MBS Digest Vol. 2, Issue 4

Beyond BMI: A Better Lens on Obesity Risk and Bariatric Outcomes and more of the latest news in metabolic news

Heart Failure, Young Patients, and Weight Recurrence

Adolescent MBS, post-op recurrence, GLP-1 combinations, AI VTE prediction, and marketplace moves shaping obesity care.

Who's Really Deciding Your Patient Needs a GLP-1 First — You or the Payer?

The evidence doesn't mandate step therapy. Increasingly, the contract does.

Blade vs Needle for MACE, Endobarrier Results, and Much More

Are you keeping up with the hottest journal articles? If not, the Digest is.

Market Update